Location History:
- Cambridge, MA (US) (2013 - 2019)
- Bradford, MA (US) (2014 - 2021)
Company Filing History:
5 out of 3,923 
1 out of 96 
1 out of 18 Years Active: 2013-2021
Title: Larry Alexander Gaither: Innovator in Pharmaceutical Combinations
Introduction
Larry Alexander Gaither is a notable inventor based in Bradford, MA (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of seven patents, showcasing his innovative approach to drug combinations and treatments.
Latest Patents
Among his latest patents, Gaither has developed a pharmaceutical combination comprising LSZ102 and ribociclib. This invention relates to a combination that is beneficial in treating or preventing conditions where degradation of estrogen receptors combined with CDK4/6 inhibition is advantageous, particularly in cancer treatment. Another significant patent involves a pharmaceutical combination comprising LSZ102 and alpelisib, which also focuses on the degradation of estrogen receptors combined with PI3K inhibition for cancer treatment.
Career Highlights
Throughout his career, Gaither has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Arrowhead Pharmaceuticals, Inc. His work has significantly impacted the development of innovative treatments in oncology.
Collaborations
Some of his notable coworkers include Mark Aron Labow and Jason Borawski, who have collaborated with him on various projects.
Conclusion
Larry Alexander Gaither's contributions to pharmaceutical innovations highlight his expertise and commitment to advancing cancer treatment. His patents reflect a deep understanding of the complexities involved in drug development and the potential for improved patient outcomes.